0001225208-23-002148.txt : 20230216 0001225208-23-002148.hdr.sgml : 20230216 20230216191547 ACCESSION NUMBER: 0001225208-23-002148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Daniel J. CENTRAL INDEX KEY: 0001595612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 23639895 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2023-02-15 0000885725 BOSTON SCIENTIFIC CORP BSX 0001595612 Brennan Daniel J. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP and CFO Common Stock 2023-02-15 4 M 0 7572.0000 7.3900 A 280954.0000 D Common Stock 2023-02-15 4 M 0 4153.0000 0.0000 A 285107.0000 D Common Stock 2023-02-15 4 F 0 1219.0000 47.2900 D 283888.0000 D Common Stock 2023-02-15 4 S 0 7572.0000 47.1378 D 276316.0000 D Deferred Stock Units 2023-02-15 4 M 0 4153.0000 0.0000 D 2023-02-15 Common Stock 4153.0000 0.0000 D Stock Option (Right to Buy) 7.3900 2023-02-15 4 M 0 7572.0000 0.0000 D 2023-02-28 Common Stock 7572.0000 0.0000 D The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.993 to $47.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 28, 2014, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 2023-02-16